microdosing glp 1 alzheimer's What you need to know about AI medical coding and GLP-1 Role of glucagon-like peptide-1 receptor

The more practical concern is absorption

"This medication has led to significant amounts of weight loss, but when it stops, patients have reported gaining up to two-thirds of that weight back," Sutton said, citing published research

94% reduction in progression from pre diabetes to type 2 diabetes with tirzepatide.** **Based on a three-year clinical trial study (176-week treatment period) sponsored by Eli Lilly and Company, weekly injections of tirzepatide significantly reduced the risk of progression to type 2 diabetes by 94% in adults with prediabetes who were overweight or obese compared to placebo

10.1038/s41419-022-04517-1 103 WeghuberD.BarrettT.Barrientos-PrezM.GiesI.HesseD.JeppesenO